Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finacea for PIH and Acne Vulgaris
NCT01038869Phase 4Completed
- Sponsor
- DermResearch
- Start
- Dec 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Azelaic acid in acne vulgaris and Post-inflammatory hyperpigmentation (PIH), sponsored by DermResearch. Primary endpoint: Percentage of Participants With Improvement in Acne IGA at 16 weeks. Started Dec 2009; status: completed.
02
Drugs
Azelaic acid
03
Conditions
acne vulgarisPost-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on NCT01038869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038869.